Lv3
274 积分 2023-12-20 加入
Deinococcus radiodurans — the consummate survivor
2天前
已完结
T cell engagers in autoimmune diseases
1个月前
已完结
Author Correction: Structural basis of assembly of the human T cell receptor–CD3 complex
1个月前
已完结
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
2个月前
已完结
FDA CDER analysis of non-human primate (NHP) data in monoclonal antibody (mAb) development to support the streamlining of nonclinical safety studies
2个月前
已完结
Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads
2个月前
已完结
Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs – an IQ DruSafe industry survey
2个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
3个月前
已完结
PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi
5个月前
已完结
皖公网安备34019202002308
